Mutagen-induced chromosome breakage
. | DEB, 0.1 μg/mL . | . | MMC, 20 ng/mL . | . | ||
---|---|---|---|---|---|---|
Patient . | Average no. of aberrations/cell . | Cells with aberrations, % . | Average no. of aberrations/cell . | Cells with aberrations, % . | ||
Kindred 1-sibling 2 | 13.12 | 98 | NE | NE | ||
Kindred 2-sibling 2 | 2.68* | 71 | 2.90* | 85 |
. | DEB, 0.1 μg/mL . | . | MMC, 20 ng/mL . | . | ||
---|---|---|---|---|---|---|
Patient . | Average no. of aberrations/cell . | Cells with aberrations, % . | Average no. of aberrations/cell . | Cells with aberrations, % . | ||
Kindred 1-sibling 2 | 13.12 | 98 | NE | NE | ||
Kindred 2-sibling 2 | 2.68* | 71 | 2.90* | 85 |
For FA, the average number of aberrations/cell after DEB is 0.66 to 11.88 and for MMC, 1.19 to 22.96. For healthy controls, respective values are 0.00 to 0.12 and 0.00 to 0.32.
NE indicates not evaluable.
Specimen obtained after therapy